Researchers at Tohoku University have developed an artificial intelligence model capable of estimating retinal age from a single fundus photograph, potentially offering a new method to screen for major diseases. Led by Professor Toru Nakazawa, the team published their findings in Communications Medicine, demonstrating that age-related changes in the retina can signal health risks beyond just chronological age. The AI model was trained on 50,595 quality-controlled images from disease-free adults and validated on an additional 7,288 images. It incorporates HbA1c data during the training phase to better recognize patterns associated with biological aging, yet requires no blood tests for clinical deployment. The system analyzes features within standard eye photographs to predict age with an average error of only three years, outperforming previous benchmarks. A key innovation of this technology is the calculation of the "retinal age gap," which represents the difference between the AI-predicted retinal age and a patient's actual chronological age. The researchers found that while the model generally predicts age accurately, a significantly larger gap exists in individuals with diabetes, heart disease, or a history of stroke. This suggests that in these patients, the retina appears biologically older than their actual years, serving as an indicator of systemic health issues. Professor Nakazawa highlighted the practical advantages of the tool, noting that fundus images are routinely taken during regular health check-ups. The AI integration would be non-invasive and require no additional patient work, fitting seamlessly into existing clinical workflows. By flagging patients with a larger retinal age gap, clinicians could identify those who may need further assessments or personalized prevention strategies. However, the researchers emphasize that current findings are based on cross-sectional analyses, meaning they establish a correlation rather than causation. To determine if retinal age can reliably predict the future onset of disease, further prospective longitudinal studies are required. In response, the team is already planning a study involving a cohort of over 10,000 individuals with a three-year follow-up period. This study aims to examine whether signals derived from retinal age are associated with the future development of cardiovascular and other systemic conditions. If successful, this technology could transform routine eye exams into powerful diagnostic tools for early disease detection. The ultimate goal is to provide a frictionless, accessible screening aid that helps doctors intervene earlier, potentially improving outcomes for patients at risk of diabetes, heart disease, and stroke without the need for complex or invasive testing procedures.